Advertisement

Topics

Latest "Glycorex Transplantation AB" News Stories

11:42 EDT 22nd October 2017 | BioPortfolio

Here are the most relevant search results for "Glycorex Transplantation AB" found in our extensive news archives from over 250 global news sources.

More Information about Glycorex Transplantation AB on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Glycorex Transplantation AB for you to read. Along with our medical data and news we also list Glycorex Transplantation AB Clinical Trials, which are updated daily. BioPortfolio also has a large database of Glycorex Transplantation AB Companies for you to search.

Showing "Glycorex Transplantation" News Articles 1–25 of 559

Sunday 22nd October 2017

Link Healthcare Pty Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102017] Prices from USD $250

SummaryLink Healthcare Pty Ltd LINK, a subsidiary of Clinigen Group Plc is a healthcare solution provider that offers generic products. The company provides therapeutic products, prescription, OTC medicines and medical devices in various therapeutic areas. It offers products such as relistor, anapen, hygroton, akineton, pentothal, valoid, zostrix, neomercazole, and others. LINK provides services s...


Gamida Cell Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102017] Prices from USD $250

SummaryGamida Cell Ltd Gamida is a cell and immune therapy company that develops transplantation and adaptive immune therapy products. The company's products comprise nicord, cordin and NK cell product. Its nicord is developed for the treatment of bone marrow transplantation for patients with high risk leukemia and lymphoma. Gamida's cordin is used for the treatment of nonmalignant orphan diseases...

Friday 20th October 2017

Mayo Foundation for Medical Education and Research Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102017] Prices from USD $250

SummaryMayo Foundation for Medical Education and Research Mayo is a nonprofit organization that provides healthcare for complex conditions through its Mayo Clinics. Mayo operates a network of hospitals, clinics and health care facilities, serving communities in Minnesota, Iowa, Georgia and Wisconsin. It also conducts research and trainings for physicians, nurses, and other health professionals. It...


Global Stem Cell Banking Market Analysis 20112017 and Forecast 20182023 [Report Updated: 22022017] Prices from USD $2980

SnapshotStem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank".The global Stem Cell Banking market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes i...

Biofortuna Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 11102017] Prices from USD $250

SummaryBiofortuna Ltd Biofortuna is a provider of contract services and molecular diagnostic products. The company distributes CEmarked, freezedried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogenetic markets. Biofortuna offers contract development and manufacturing services. It also offers contract IVD ...

Global Mesenchymal Stem Cells Market Analysis 20112017 and Forecast 20182023 [Report Updated: 08032017] Prices from USD $2980

SnapshotMesenchymal stem cells, or MSCs, are multipotent stromal cells that can differentiate into a variety of cell types, including: osteoblasts bone cells, chondrocytes cartilage cells, myocytes muscle cells and adipocytes fat cells.The global Mesenchymal Stem Cells market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and ...

Thursday 19th October 2017

Label-Free Detection Market - Drug Discovery Programs in the Americas to Boost Sales | Technavio

The global label-free detection (LFD) market is expected to grow at an impressive CAGR of close to 11% during the forecast period, according to Technavio’s latest market research. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006025/en/

Global and Asia Mesenchymal Stem Cells Market Status and Future Forecast 20132023 [Report Updated: 13102017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Wednesday 18th October 2017

City of Hope, Leading Cancer Research and Treatment Center, to Provide First-Ever FDA-Approved CAR-T Cell Therapy for Adult Patients with Certain Types of Large B-cell Lymphoma

The cancer center will be one of the first in the nation to offer axicabtagene ciloleucel, a significant breakthrough in treatment for one of the most common cancers in the U.S. City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will be one of the first authorized centers in the nation to provide ax...

Tuesday 17th October 2017

Orgenesis to Present at BIO Investor Forum

GERMANTOWN, MD -- (Marketwired) -- 10/18/17 -- Orgenesis Inc., (OTCQB: ORGS) ("Orgenesis " or "the Company"), a vertically-integrated biopharmaceutical company with expertise and unique experience in cell therapy development and manufacturing, today announced that it will present at the BIO Investor Forum being held October 17-18, 2017 in San Francisco, CA. Vered Caplan, Chief Executive Officer ...

Takeda and HemoShear Therapeutics Collaborate for Liver Disease Therapies

Takeda Pharmaceutical Company Limited and HemoShear Therapeutics, a privately held biotechnology company, are starting a partnership to discover and develop novel therapeutics for liver diseases, including nonalcoholic steatohepatitis (NASH).   "The ability to study pathophysiology in a human multi-cell system is crucial for our understanding of disease and how to develop best-in-class thera...

Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 2017

OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that it plans to release third quarter 2017 financial results prior to market open on ...

Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) is pleased to provide a scientific update to its stockholders. The Company is exploring the following areas for the use of its AAGP™ family of molecules: Presen

Takeda and HemoShear Therapeutics Enter into Exclusive Drug Discovery Partnership in Liver Diseases

Deal combines HemoShear’s REVEAL-Tx™ platform with Takeda’s drug discovery and development capabilities Takeda Pharmaceutical Company Limited (TSE: 4502) and HemoShear Therapeutics, LLC,

Monday 16th October 2017

Hackensack University Medical Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryHackensack University Medical Center HackensackUMC, a subsidiary of Hackensack University Health Network is a health care service provider. The center offers medical, surgical, hospital, and emergency services. Its services include education, health information and guest services, nutrition and food management, bioethics, pastoral care, retail pharmacies, and radiology. Hackensack provides ...

RPharm Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102017] Prices from USD $250

SummaryRPharm is a pharmaceutical company that manufactures and commercializes products for various therapeutic areas. The company's portfolio includes products for various therapies that include oncology, hematology, cardiology, immunology; and antibacterial and antiviral diseases. It focuses on the treatment of HIVinfection, organ transplantation, disseminated sclerosis, hemophilia, and diabetes...

Hematopoietic Stem Cells Transplantation Market – Over 50% Incremental Growth to Originate from EMEA | Technavio

LONDON–(BUSINESS WIRE)–#HSCT–The global hematopoietic stem cells transplantation (HSCT) market is expected to grow at an impressive CAGR of close to 6% during the forecast period, according to Technavio’s latest market research. In this market research report, Technavio covers the market … Continue reading → Cet article Hematopoietic Stem Cells Transplantation Marke...

Hematopoietic Stem Cells Transplantation Market - Over 50% Incremental Growth to Originate from EMEA | Technavio

The global hematopoietic stem cells transplantation (HSCT) market is expected to grow at an impressive CAGR of close to 6% during the forecast period, according to Technavio’s latest market research. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171016005794/en/

Omeros Announces Upcoming Presentation of Clinical OMS721 Data at European Society for Blood and Marrow Transplantation

Omeros Corporation (NASDAQ: OMER) today announced that data will be presented from the company’s Phase 2 clinical trial of OMS721, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), for the treatment of thrombotic microangiopathies (TMAs). The presentation will be part of the “Crash course on...

Alpine Immune Sciences Announces Upcoming Scientific Presentations

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for autoimmune/inflammatory diseases and cancer, today announced planned poster presentations highlighting recent data at the following scientific meetings: Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting ...

Saturday 14th October 2017

Global Hospital Care Partnering 20102017: Deal trends, players and financials [Report Updated: 01102017] Prices from USD $3495

Global Hospital Care Partnering 2010 to 2017 provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Hospital Care partnering dealsFinancial deal terms for headline, upfront and royalty by stage of developmentHospital Care partnering agreement structureHospital Care partnering contract documentsTop Hosp...

Friday 13th October 2017

Novartis Korea Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryNovartis Korea Co Ltd NKC, a subsidiary of Novartis AG is a drug developer that offers tumor care drugs. The company's product categories comprise diabetes solvents, malignant tumor, best emetic, antiemetics, general inspection for reagents, smoking cessation aids, antihypertensive, antidote, parasitic skin disease solvent, chemotherapeutic agents and atherosclerosis, among others. It also ...

Kamada Ltd KMDA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryKamada Ltd Kamada is a biopharmaceutical company that develops, manufactures and markets specialty proteins, specific immunoglobulins and other prescription medicines. The company's product include glassia, a intravenous plasmaderived alpha1 antitrypsin product, which is used for the treatment of patients with emphysema secondary to congenital AAT deficiency. It also offers products for the...

AastromReplicell System Enables Ex Vivo Production of Human Stem Cells

An article in the July 6 edition of the Proceedings of the National Academy of Sciences (PNAS) stresses the therapeutic importance of developing new approaches for expanding a cancer patient's stem cells ex vivo for possible re-transplantation following chemotherapy...

Global and Regional Mesenchymal Stem Cells Market Research Report 2017 [Report Updated: 05102017] Prices from USD $3500

SummaryMesenchymal stem cells, or MSCs, are multipotent stromal cells that can differentiate into a variety of cell types, including: osteoblasts bone cells, chondrocytes cartilage cells, myocytes muscle cells and adipocytes fat cells.Market Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type MSCBM MSCUC MSCAT OthersBy A...


Quick Search
Advertisement
 

News Quicklinks